Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Fingolimod in Minimal Invasive Treatment of Intracerebral Hemorrhage

NCT06087965 is registered in ClinicalTrials.gov with Tang-Du Hospital as lead sponsor.

NCT NCT06087965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06087965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Fingolimod in Minimal Invasive Treatment of Intracerebral Hemorrhage
Lead sponsor
Tang-Du Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 11, 2023
Completion date
December 30, 2025
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage